RVL Pharmaceuticals plc
RVLPDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739426
RVL Pharmaceuticals plc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Oct 23, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $1.57M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in RVL Pharmaceuticals plc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +8 vs. Q2 2022
- Shares held
- 24.0M
- +7.68M (+46.9%) vs. Q2 2022
- Total value
- $50.5M
- +$28.3M (+127.4%) vs. Q2 2022
- New holders
- 15
- 8 more added
- Sold out
- 7
- 8 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVLP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 3 | $613 |
| Q3 2023 | 32 | $1.57M |
| Q2 2023 | 36 | $13.5M |
| Q1 2023 | 41 | $28.7M |
| Q4 2022 | 36 | $28.0M |
| Q3 2022 | 46 | $50.5M |
| Q2 2022 | 38 | $22.2M |
| Q1 2022 | 36 | $27.8M |
| Q4 2021 | 31 | $18.7M |
| Q3 2021 | 35 | $11.9M |
| Q2 2021 | 46 | $14.5M |
| Q1 2021 | 55 | $25.7M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding RVL Pharmaceuticals plc; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Athyrium Capital Management, LP | 14,600,444 | $30.7M | 11.48% | +6,451,612+79.2% | Added |
| Rovida Advisors Inc. | 3,000,000 | $6.30M | 2.93% | 00.0% | Unchanged |
| ArrowMark Colorado Holdings LLC | 1,623,000 | $3.41M | 0.04% | 00.0% | Unchanged |
| Morgan Stanley | 1,173,204 | $2.46M | 0.00% | −47,549−3.9% | Reduced |
| Renaissance Technologies LLC | 772,007 | $1.62M | 0.00% | −68,500−8.1% | Reduced |
| AIGH Capital Management LLC | 739,531 | $1.55M | 0.61% | +654,538+770.1% | Added |
| Geode Capital Management, LLC | 304,382 | $639.0K | 0.00% | +41,605+15.8% | Added |
| UBS Oconnor LLC | 276,428 | $580.0K | 0.01% | +276,428 | New |
| Vanguard Group Inc | 222,435 | $467.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 201,419 | $423.0K | 0.00% | −5,759−2.8% | Reduced |
| Worth Venture Partners, LLC | 185,647 | $390.0K | 0.24% | +185,647 | New |
| Millennium Management LLC | 162,228 | $341.0K | 0.00% | +114,103+237.1% | Added |
| Marietta Wealth Management, LLC | 120,000 | $252.0K | 0.06% | 00.0% | Unchanged |
| Titleist Asset Management, Ltd. | 98,151 | $206.0K | 0.05% | −20,152−17.0% | Reduced |
| Dimensional Fund Advisors LP | 86,361 | $182.0K | 0.00% | +13,738+18.9% | Added |
| State Street Corp | 72,187 | $152.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 64,472 | $135.0K | 0.00% | −6,619−9.3% | Reduced |
| Insight Advisors, LLC | 37,823 | $79.0K | 0.03% | 00.0% | Unchanged |
| Raymond James Financial Services Advisors, Inc. | 29,519 | $62.0K | 0.00% | +29,519 | New |
| Atria Wealth Solutions, Inc. | 27,000 | $56.7K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 23,717 | $49.0K | 0.00% | −157−0.7% | Reduced |
| Virtu Financial LLC | 22,835 | $48.0K | 0.00% | +22,835 | New |
| Citadel Advisors LLC | 21,561 | $46.0K | 0.00% | +21,561 | New |
| IPG Investment Advisors LLC | 17,500 | $36.8K | 0.01% | +17,500 | New |
| Two Sigma Securities, LLC | 16,298 | $34.0K | 0.00% | +16,298 | New |
| Tower Research Capital LLC (TRC) | 15,483 | $32.0K | 0.00% | +15,483 | New |
| Susquehanna International Group, LLP | 14,663 | $31.0K | 0.00% | +14,663 | New |
| Two Sigma Advisers, LP | 14,100 | $30.0K | 0.00% | −3,300−19.0% | Reduced |
| Charles Schwab Investment Management Inc | 13,322 | $28.0K | 0.00% | −19,391−59.3% | Reduced |
| Bank of New York Mellon Corp | 12,078 | $25.0K | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 11,300 | $24.0K | 0.00% | +11,300 | New |
| UBS Group AG | 11,394 | $23.0K | 0.00% | +11,169+4,964.0% | Added |
| Ergoteles LLC | 10,927 | $23.0K | 0.00% | +10,927 | New |
| SFMG, LLC | 10,000 | $21.0K | 0.00% | 00.0% | Unchanged |
| Williams Jones Wealth Management, LLC. | 10,000 | $21.0K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 8,356 | $18.0K | 0.00% | +8,356 | New |
| Tower View Investment Management & Research LLC | 4,100 | $9.00K | 0.01% | 00.0% | Unchanged |
| Barclays PLC | 2,849 | $6.00K | 0.00% | +2,849 | New |
| Bank of America Corp | 1,720 | $4.00K | 0.00% | +1,719+171,900.0% | Added |
| Huntington National Bank | 1,650 | $3.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,187 | $2.00K | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 306 | $2.00K | 0.00% | +306 | New |
| Royal Bank of Canada | 294 | $1.00K | 0.00% | +210+250.0% | Added |
| Tilia Fiduciary Partners, Inc. | 435 | $1.00K | 0.00% | +435 | New |
| BNP Paribas Arbitrage, SA | 7 | $15 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Prudential Financial Inc | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −22,413−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −21,870−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,598−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −75−100.0% | Sold out |